Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Net Cash Flow (2023 - 2024)

Exozymes (EXOZ) has disclosed Net Cash Flow for 2 consecutive years, with $9.5 million as the latest value for Q4 2024.

  • Quarterly Net Cash Flow rose 2424.72% to $9.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $9.7 million through Dec 2024, changed N/A year-over-year, with the annual reading at -$6.7 million for FY2025, 169.2% down from the prior year.
  • Net Cash Flow for Q4 2024 was $9.5 million at Exozymes, up from $75696.0 in the prior quarter.
  • The five-year high for Net Cash Flow was $9.5 million in Q4 2024, with the low at -$408023.0 in Q4 2023.